Becker’s Healthcare Podcast Balancing Margin, Shortages, & 340B Risks in 2026
Mar 19, 2026
AJ Rivosecchi, product director and trained pharmacist who focuses on pharmacy procurement and 340B compliance. He discusses making procurement strategic by unsiloing data. He covers integrating supply, finance, and compliance systems. He talks about using shortage predictions for planning and protecting 340B compliance amid changing risk.
AI Snips
Chapters
Transcript
Episode notes
Procurement Must Become A Strategic Cross Functional Function
- Pharmacy procurement must move from siloed buying to a strategic, cross-functional function combining supply chain, finance, and compliance.
- Unsiloing data lets organizations optimize margins while ensuring operational access and regulatory confidence across teams.
AI Shift Made Unsiloing Data A Practical Expectation
- Awareness of AI and analytics shifted expectations: data no longer should live in silos and can be combined to generate new insights.
- This cultural shift accelerates unsiloing and enables strategic procurement decisions using existing datasets.
Use Resiliency Data To Inform Formulary Choices
- Integrate supply chain resiliency data into procurement decisions to weigh cost versus availability when selecting drugs.
- Compare drug cost and predicted disruption risk across therapeutic categories so you can defensibly choose higher-cost but more reliable products.